Astek Group × Keyrus Group
Astek Group acquired the Life Sciences CRO activities of the Keyrus Group, a unit with 190 employees and €23.5m in 2024 revenue. [75] The acquisition is part of Astek's strategy to become a key player in the digital transformation of Life Sciences by combining its engineering skills with Keyrus's clinical data expertise. [60] The financial terms of the acquisition were not disclosed. [75]
The asset
The entire Life Sciences Contract Research Organization (CRO) business unit, specializing in clinical trial data management, biostatistics, and regulatory services. [60, 63]
The record
- Seller status
- Going concern
- Sector
- Data and digital consulting
- Modalities
- clinical_data, text
What it means if you hold data
This transaction illustrates the consolidation trend in the CRO market, where data management and biostatistics capabilities are key assets. It shows how engineering and IT consulting firms are acquiring specialized clinical data businesses to offer end-to-end services to pharmaceutical clients, from tech deployment to clinical trial data analysis. [63, 78]